CS

Chenlur Subramani Priya

Active Director Designated Partner DIN 10010642
DIN 10010642 First appointment Jul 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Chenlur Subramani Priya

Data last updated:

Chenlur Subramani Priya is a Designated Partner at Maha Sakthi Narayani Hospital Llp (since 2022). The company operates in Healthcare.

DIN 10010642
Primary Designation Designated Partner
Industry Healthcare
First Appointment 12 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Jul 20222022Active

Board colleagues of Chenlur Subramani Priya

NameDINCompanyDesignation
Sreenivas Nrusimha Devaganapalli10010643Maha Sakthi Narayani Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Maha Sakthi Narayani Hospital Llp
Premium access

Shareholding and investment profile for Chenlur Subramani Priya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chenlur Subramani Priya

Chenlur Subramani Priya currently holds 1 directorship: Maha Sakthi Narayani Hospital Llp (Designated Partner, since 12 Jul 2022).

Chenlur Subramani Priya was first appointed on 12 Jul 2022 as Designated Partner at Maha Sakthi Narayani Hospital Llp.

The current boards of Chenlur Subramani Priya's companies include Sreenivas Nrusimha Devaganapalli (Maha Sakthi Narayani Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available